Mitsui Global Investment is a company that provides financial support and guidance to entrepreneurs with innovative business plans and aspirations.

Mitsui Global Investment

Here at Mitsui Global Investment, we get excited about cutting-edge technologies and scientific breakthroughs. Passionate entrepreneurs and forward-thinking investors inspire us, and we hope to do the same.  

We enjoy getting to know the teams we invest in and cherish opportunities to help out and provide value-add support.  With the diversity and knowledge amassed through our years as a global enterprise, we bring a fresh eye to new business.  

We have been investing for over 20 years in venture opportunities with over 100 portfolio companies and 35 exits, and are currently seeking new investment opportunities.  

Please visit our website us if you'd like to learn more.

Mitsui & Co. Global Investment, Inc.

Congratulations to the QurAlis team for closing a licensing deal with Eli Lilly for the development of their QRL-204 compound.  This compound will potentially restore UNC13a function in patients with ALS and FTD. Amazing work! https://lnkd.in/ePTXJvH9 Kasper Roet Dan Elbaum Angela Genge, MD, FRCP(C), eMBA Vikas Sharma Anne Whitaker Johannes Fruehauf Chris Thomajan Kristine Kelly, MBA Roel Bulthuis Ivan Burkov Jeffrey Moore Peter Wallach Jonathan Behr Kiyoshi Okubo Sunao Nishimura Aya Runderkamp Kazufumi Nakamura Kinji Fuchikami Yukitaka Kojima, CFA Irene Mingozzi Orie Schneider Sue Yasuko Nagakura Makiko Kikuchi Qing (Susie) Shen Yasuhiro S. Atsuko Chitose Michael S. Yu Reiko Namikawa, MD. Ph.D. Yoichiro Miwa Caroline Pinkney

Great update from our newest portfolio company, Reunion Neuroscience, who just published results from their preclinical studies.  Excellent work and one step further in developing a therapeutic to treat depressive disorders! Welcome to the Mitsui family! Kazufumi Nakamura Yukitaka Kojima, CFAQing (Susie) Shen  Kiyoshi Okubo Sunao Nishimura Makiko Kikuchi  Aya Runderkamp Orie Schneider Kinji Fuchikami Irene Mingozzi Caroline Pinkney 
https://lnkd.in/drsquEYU

We are happy to announce the closing of Leash Laboratories' seed financing round, one of our newest portfolio companies innovating the drug discovery space. Congratulations to the Leash team! Yukitaka Kojima, CFA

Metric
Company Name	Mitsui Global Investment
Symbol
MSH ID	COM:MITSUI-GLOBAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment
Country	US
Stage
Employee Count	12
Website	mitsui-global.com
LinkedIn	mitsui-co-global-investment-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MITS

COM:MITSUI-GLOBAL

Mitsui Global Investment

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue